PS1 FAD mutants decrease ephrinB2-regulated angiogenic functions, ischemia-induced brain neovascularization and neuronal survival
Yonejung Yoon,Georgios Voloudakis,Nathan Doran,Emily Zhang,Christina Dimovasili,Lei Chen,Zhiping Shao,Spyros Darmanis,Cheuk Y. Tang,Jun Tang,Victoria X. Wang,Patrick R. Hof,Nikolaos K. Robakis,Anastasios Georgakopoulos +13 more
6
TL;DR: Together, the data show that PS1 FAD mutations impede the EphB4/ephrinB2-mediated angiogenic functions of ECs and impair brain neovascularization, neuronal survival and cognitive recovery following ischemia.
read more
Abstract: Microvascular pathology and ischemic lesions contribute substantially to neuronal dysfunction and loss that lead to Alzheimer disease (AD). To facilitate recovery, the brain stimulates neovascularization of damaged tissue via sprouting angiogenesis, a process regulated by endothelial cell (EC) sprouting and the EphB4/ephrinB2 system. Here, we show that in cultures of brain ECs, EphB4 stimulates the VE-cadherin/Rok-α angiogenic complexes known to mediate sprouting angiogenesis. Importantly, brain EC cultures expressing PS1 FAD mutants decrease the EphB4-stimulated γ-secretase cleavage of ephrinB2 and reduce production of the angiogenic peptide ephrinB2/CTF2, the VE-cadherin angiogenic complexes and EC sprouting and tube formation. These data suggest that FAD mutants may attenuate ischemia-induced brain angiogenesis. Supporting this hypothesis, ischemia-induced VE-cadherin angiogenic complexes, levels of neoangiogenesis marker Endoglin, vascular density, and cerebral blood flow recovery, are all decreased in brains of mouse models expressing PS1 FAD mutants. Ischemia-induced brain neuronal death and cognitive deficits also increase in these mice. Furthermore, a small peptide comprising the C-terminal sequence of peptide ephrinB2/CTF2 rescues angiogenic functions of brain ECs expressing PS1 FAD mutants. Together, our data show that PS1 FAD mutations impede the EphB4/ephrinB2-mediated angiogenic functions of ECs and impair brain neovascularization, neuronal survival and cognitive recovery following ischemia. Furthermore, our data reveal a novel brain angiogenic mechanism targeted by PS1 FAD mutants and a potential therapeutic target for ischemia-induced neurodegeneration. Importantly, FAD mutant effects occur in absence of neuropathological hallmarks of AD, supporting that such hallmarks may form downstream of mutant effects on neoangiogenesis and neuronal survival.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
The amyloid cascade hypothesis: an updated critical review.
Kasper Planeta Kepp,Nikolaos K. Robakis,Poul Flemming Høilund-Carlsen,Stefano L. Sensi,Bryce Vissel +4 more
TL;DR: This paper reviewed the history and weaknesses of the amyloid cascade hypothesis in view of the new evidence obtained from clinical trials of anti-amyloid antibodies and argued that the data point to Aβ playing a minor etiological role.
103
Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene
TL;DR: Genetic modifiers may play a critical role in the age of disease onset and clinical phenotypes of PSEN1 mutations, and possible significant residues of the protein are introduced.
Recent Advances on Cell-Based Co-Culture Strategies for Prevascularization in Tissue Engineering
TL;DR: In this article, the authors investigated the recent advances on standard cells used in in vitro pre-vascularization methods, their co-culture systems, and conditions in which they formed an organized and functional vascular network.
38
An Amyloid Agnostic Reformulation of the Alzheimer’s Disease: The Long Gene Vulnerability Hypothesis
Sourena Soheili-Nezhad
- 23 Aug 2021
TL;DR: The long gene vulnerability hypothesis provides a simple link between aging and the genetic landscape of AD and warrants new strategies for disease modification.
•Journal Article
After the stroke.
Laura Jarmer,Rebecca Fielding +1 more
TL;DR: There are no concerns that arise if a person recovering from a stroke begins an exercise regimen that starts within 24 hours after the stroke, according to the lead author of an article published in this issue of Neurology®,.
References
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
TL;DR: In this article, the role of the neurovascular unit and molecular mechanisms in vascular cells behind Alzheimer's disease and CAA pathogenesis was discussed. But, the authors did not consider the effect of microglia and perivascular macrophages in Aβ clearance from the brain.
Enlarged Infarcts in Endothelial Nitric Oxide Synthase Knockout Mice Are Attenuated by Nitro-l-Arginine
Zhihong Huang,Paul L. Huang,Jianya Ma,Wei Meng,Cenk Ayata,Mark C. Fishman,Michael A. Moskowitz +6 more
TL;DR: It is concluded that NO production within endothelium may protect brain tissue, perhaps by hemodynamic mechanisms, whereas neuronal NO overproduction may lead to neurotoxicity.
737
Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease?
TL;DR: This questionnaire disclosed striking differences between patients with FTD and AD, but only stereotypic behaviour, changes in eating preference, disinhibition, and features of poor social awareness reliably separated the groups.
Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood
TL;DR: A well-characterized nucleic acid proximity-based assay using antibodies, called Proximity Extension Assay (PEA), showing good performance in plasma samples, and the use of a macro-molecular crowding matrix in combination with this homogeneous assay to drive target binding for low-affinity antibodies, thereby improving the sensitivity and increasing affinity reagent availability by lowering assay development dependency on high-Affinity antibodies.
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
Suphansa Sawamiphak,Sascha Seidel,Clara L. Essmann,George A. Wilkinson,Mara E. Pitulescu,Till Acker,Amparo Acker-Palmer +6 more
TL;DR: It is suggested that blocking ephrin-B2 reverse signalling may be an attractive alternative or combinatorial anti-angiogenic therapy strategy to disrupt VEGFR2 function in tumour angiogenesis.
563